When implementing a screening protocol in an asymptomatic cohort, we must be cautious with respect to the risk-benefit ratio so that we do not inadvertently produce net harm to the patients.
Contrast-induced nephropathy associated with coronary CTA and ICA is of particular concern if screening is to be performed before initiation of dialysis. In the described cohort, 15% of patients were started on dialysis after coronary CTA and within 30 days of ICA. Finally, it may be prudent to use imaging in a subset of patients at clinically high risk of events rather than in the entire population if the purpose is to identify patients with 3-vessel CAD (only 2% in this cohort). The scientific statement from the American Heart Association (5) provides a starting point. Further research is needed, however,
to determine who will benefit from imaging during evaluation before renal transplantation and how to intervene to decrease risk in response to imaging findings (7).
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